NCT06225271

Effects of the Combined Intervention of Exercise, Fruit, and Vitamin Supplementation on Frailty in Older Adults

Effects of the Combined Intervention of Exercise, Fruit, and Vitamin Supplementation on Frailty in Older Adults: A Cohort-based Cluster- Randomized Controlled Trial
Nanjing Medical University·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Frailty
Drug/Device/Intervention
the combined intervention of exercise, fruit, and vitamin supplementation
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Nanjing Medical University
Timeline & enrollment
Phase
N/A
Start date
Feb 25, 2024
End date
Mar 01, 2026
Enrollment
934 participants
Primary outcome

The change in handgrip strength at 12 months from baseline.

Summary

The goal of this cohort-based cluster-randomized controlled trial is to investigate the
 effect of the combined intervention of exercise, fruit, and vitamin supplementation on
 frailty among older adults. Older individuals aged 65~80 years old with low physical activity
 levels and low fruit intake will be recruited. 14 clusters will be randomized into 2 arms
 with 1:1 ratio. Participants in the intervention arm will receive the combined intervention
 of physical activity, fruit, and vitamin supplementation 3 times a week for 2 months (the 1st
 and 6th months). They will also be given group interventions, such as self-management group
 activity or health education, at least once a week. Participants in the control arm will not
 receive any intervention.

ICD-10 classifications
Unattended deathIndividuals with autosomal fragile site
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06225271
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06225271 through Pure Global AI's free database. This phase not specified trial is sponsored by Nanjing Medical University and is currently Not yet recruiting. The study focuses on Frailty. Target enrollment is 934 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.